Can-Fite BioPharma Ltd.

About Can-Fite BioPharma Ltd.

Can-Fite BioPharma is an Israeli biopharmaceutical company with integrated pharmaceutical discovery and clinical development capabilities. It focuses on developing proprietary drug candidates in Phase II and III clinical trials for oncology, inflammatory, and metabolic diseases using its platform technology targeting the A3 adenosine receptor (A3AR).

Products & Services

Piclidenoson (CF101):A drug candidate for the treatment of psoriasis, currently in clinical development.

CF602:A drug candidate under development, specific details not provided.

Specialties

Oncology Inflammatory Diseases Metabolic Diseases A3 Adenosine Receptor (A3AR) Technology Drug Development (Phase II and III Clinical Trials)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 3000000 MR: - FA: $3.0 Million FAN: 3000000	D: 2025-04-14 FD: 2025-04-14	-
2	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 5000000 MR: - FA: Approximately $5.0 million FAN: 5000000	D: 2024-08-08 FD: 2024-08-08	-

Registered Direct Offering Latest

2025-04-14

$3.0M

Warrant Exercise 2024-08-08

$5.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Pnina Fishman

Executive Chairperson, CSO

LinkedIn (Pro only)

Y

Yossi Borenstein

Director

Y

Yaacov Goldman

Director of Can-Fite

G

Guy Regev

Director at Can-Fite BioPharma

A

Abraham Sartani

Director

Y

Yossi Bornstein

View 8 more team members with Pro

Unlock Full Team Directory

Recent News